metricas
covid
Buscar en
Actas Urológicas Españolas (English Edition)
Toda la web
Inicio Actas Urológicas Españolas (English Edition) BCG unresponsive non-muscle invasive bladder cancer: The beginning of a new era?
Journal Information
Vol. 47. Issue 6.
Pages 329-331 (July - August 2023)
Share
Share
Download PDF
More article options
Vol. 47. Issue 6.
Pages 329-331 (July - August 2023)
Editorial
BCG unresponsive non-muscle invasive bladder cancer: The beginning of a new era?
Cáncer de vejiga no músculo invasivo que no responde a bacilo de Calmette-Guérin: ¿el inicio de una nueva era?
Visits
5
F. Guerrero-Ramosa,b,c
a UroOncology Unit, Department of Urology, Hospital Universitario 12 de Octubre, Madrid, Spain
b ROC Clinic, Madrid, Spain
c Hospital Universitario HM Sanchinarro, Madrid, Spain
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Tables (1)
Table 1. Efficacy results of drugs currently approved by the FDA for the treatment of BCG-unresponsive NMIBC (N/A: not available).

Article

These are the options to access the full texts of the publication Actas Urológicas Españolas (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Actas Urológicas Españolas (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos